Ortin Global
Ortin Global Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Ortin Global Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Valuation
Profitability
Growth
Financial Health
Ortin Global Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Ortin Global Ltd, switchable between annual and quarterly views, consolidated or standalone.
Ortin Global Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹13.19 Cr and reported EPS of ₹-1.13.
Ortin Global segment analysis: revenue and profit mix.
Disclosed business segments at Ortin Global with their share of revenue and profit, switchable between consolidated and standalone reporting.
Ortin Global discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Ortin Global Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Ortin Global Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Ortin Global Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Ortin Global Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Ortin Global Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Ortin Global Ltd — derived from the live tape, not yesterday's close.
Ortin Global Ltd last traded at ₹18.02 with an intraday range of ₹16.6–₹18.41 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹18.02| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 22.37 | +4.35 | +24.16% |
| R3 | 20.56 | +2.54 | +14.11% |
| R2 | 19.49 | +1.47 | +8.14% |
| R1 | 18.75 | +0.73 | +4.07% |
| PIVOT | 17.68 | -0.34 | -1.91% |
| CURRENT | 18.02 | — | — |
| S1 | 13.32 | -4.70 | -26.06% |
| S2 | 15.13 | -2.89 | -16.02% |
| S3 | 15.87 | -2.15 | -11.95% |
| S4 | 16.94 | -1.08 | -5.97% |
ORTINGLOBE is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ~
Trading Inside opening range
Ortin Global Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Ortin Global Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Ortin Global Ltd stood at 61.2% of traded volume, against a 20-day average of 80.3%.
Ortin Global announcements: results, concalls, ratings, M&A.
Filings Ortin Global sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Ortin Global files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 34 documents below.
Updates
Rarever Financial Advisors Private Limited has submitted to the Exchange a copy of Pre-offer advertisement cum corrigendum of the public…
Updates
Rarever Financial Advisors Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Recommendations of the Committee of Independent…
Updates
ORTIN GLOBAL LIMITED has informed the Exchange regarding 'Reporting of Annual Disclosure to be made by an entity identified as a Large Corporate'.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
ORTIN GLOBAL LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Corrigendum
Rarever Financial Advisors Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Corrigendum to the detailed public statement for…
Ortin Global dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Ortin Global has declared, sequenced by announce and record date.
Ortin Global corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Ortin Global Ltd: business, sector, key facts.
What Ortin Global Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Ortin Global Ltd operates in the Pharmaceuticals industry under the Health Care sector, listed as NSE: ORTINGLOBE, BSE: 539287.
Ortin Global Limited is a pharmaceutical company based in Hyderabad, India, established in 1986 and rebranded in June 2024. Its primary business revolves around the manufacture and trade of pharmaceuticals, drugs, and their intermediate components within the Indian market and potentially for export.
The company operates through two main segments: manufacturing and trading. The manufacturing segment focuses on a wide array of pharmaceutical formulations, encompassing various therapeutic categories. These include tablets, capsules, syrups, and dry powders targeting conditions such as diabetes, allergies, cardiovascular issues, infections (bacterial, fungal, parasitic), pain, and gastrointestinal problems. Their product portfolio also extends to psychiatric medications, nutritional supplements (vitamins, proteins, enzymes), and anti-retroviral drugs.
Beyond finished formulations, Ortin Global also manufactures active pharmaceutical ingredients (APIs) and their intermediates. This vertical integration allows them to control a significant portion of their supply chain. The APIs manufactured include those used in anti-retrovirals, diabetes treatments, pain relievers, antibiotics, antifungals, antacids, and anti-malarial drugs. They also produce fine chemicals and organometallic compounds like Grignard reagents.
Complementing its manufacturing capabilities, Ortin Global provides a range of research and development services. These services encompass process development and optimization, product characterization, analytical testing (assay development), and formulation development for new brands. Furthermore, they offer diagnostic services including the development of rapid diagnostic kits and reagents. The company also undertakes long-term contracts for the custom manufacturing of intermediates and the development of new APIs.
In addition to its core pharmaceutical operations, Ortin Global engages in the export of finished pharmaceutical formulations and holds real estate assets. The company’s diversified business model combines manufacturing, trading, research and development, and real estate holdings, contributing to its overall revenue streams.
Questions investors ask about Ortin Global Ltd (ORTINGLOBE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Ortin Global Ltd (ORTINGLOBE)?
The current share price of Ortin Global Ltd (ORTINGLOBE) is ₹18.02. Today, the stock has gained by ₹0.09 (0.50%), trading in a range of ₹16.6 to ₹18.41. The stock opened at ₹17.7 with a trading volume of 48,801 shares.
02Is Ortin Global Ltd stock a good investment for long-term?
Ortin Global Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹13.19 crores, P/E ratio of 0.00, ROE of -30.12%, and ROCE of 0.00%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Ortin Global Ltd stock?
The 52-week high price of Ortin Global Ltd (ORTINGLOBE) is ₹21.3, while the 52-week low is ₹10.66. Currently trading at ₹18.02, the stock is 69.2% away from its 52-week low and 15.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Ortin Global Ltd stock at the current price?
Whether to buy Ortin Global Ltd stock at ₹18.02 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 6.34. Today's performance shows a gain of 0.50%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Ortin Global Ltd and when is the next dividend?
Ortin Global Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹18.02, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Ortin Global Ltd?
Ortin Global Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 6.34, ROE: -30.12%, ROCE: 0.00%, Dividend Yield: 0.00%, EPS: ₹-1.13, Book Value: ₹2.43, and Debt-to-Equity: 0.13. The company's market cap stands at ₹13.19 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Ortin Global Ltd stock performing today in the market?
Ortin Global Ltd stock opened at ₹17.7 and is currently trading at ₹18.02, showing a gain of ₹0.09 (0.50%). The intraday high is ₹18.41 and low is ₹16.6. The trading volume stands at 48,801 shares, indicating moderate market participation today.
08What is the P/E ratio of Ortin Global Ltd and what does it indicate?
Ortin Global Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-1.13, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Ortin Global Ltd (ORTINGLOBE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs & Pharmaceuticals (AKUMS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy